A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.
Clin Cancer Res
; 7(1): 58-67, 2001 Jan.
Article
em En
| MEDLINE
| ID: mdl-11205919
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Protocolos de Quimioterapia Combinada Antineoplásica
/
Carboplatina
/
Fator Estimulador de Colônias de Granulócitos
/
Interleucina-6
/
Etoposídeo
/
Ifosfamida
/
Neoplasias
Tipo de estudo:
Incidence_studies
/
Risk_factors_studies
Limite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Idioma:
En
Revista:
Clin Cancer Res
Ano de publicação:
2001
Tipo de documento:
Article